Thus, unlike other CD1d-deficient tumors, treatment of CD1d-expressing breast tumors with an anti-CD1d blocking antibody significantly increases spontaneous tumor metastasis in vivo, demonstrating the importance of CD1d expression for iNKT-mediated antitumor immunity. This evidence concerns the gene CD1D and breast neoplasm.